Covered recipient · General Payments record
MICHAEL J SLADE
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2020–2024
$8,749.70
- Reported across 11 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $7,875.25 | 2 |
| Food and Beverage | $597.56 | 6 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| F. Hoffmann-La Roche AG | $8,154.71 | 3 |
| GENZYME CORPORATION | $139.22 | 2 |
| Kite Pharma, Inc. | $130.35 | 1 |
| Legend Biotech USA Inc. | $33.53 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $15.00 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101221338 | CMS |
| F. Hoffmann-La Roche AG | $6,466.51 | 04/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1133072200 | CMS |
| F. Hoffmann-La Roche AG | $1,408.74 | 04/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1133072204 | CMS |
| F. Hoffmann-La Roche AG | $279.46 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133072209 | CMS |
| GENZYME CORPORATION | $5.73 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139716894 | CMS |
| GENZYME CORPORATION | $133.49 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139716926 | CMS |
| Kite Pharma, Inc. | $130.35 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128612905 | CMS |
| Legend Biotech USA Inc. | $33.53 | 12/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131694394 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.